Awinsa Life Sciences Private Limited

Awinsa Life Sciences Private Limited - business outsourcing in Delhi, India. FY 2026 financials & compliance.
CIN U74999DL2018PTC395289 Incorporated 17 April 2018 ROC Delhi HQ Delhi, India
Active Private Limited Company business outsourcing
Revenue · FY 2024
₹21.69 Cr
▲ 33% YoY
Net profit · FY 2024
₹6.84 Cr
Net margin 31.5%
EBITDA · FY 2024
₹9.61 Cr
EBITDA margin 44.3%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹6 Lakh
Issued & subscribed
Company age
8 yrs
Est. 2018
Employees · EPFO
38
Provident fund records
Directors on board
2
As per MCA filings

About Awinsa Life Sciences Private Limited

Data last updated:

Awinsa Life Sciences Private Limited is a private limited company based in Delhi, India. It operates in the medical transcription segment of the business process outsourcing sector. It was incorporated on 17 April 2018 and has been in existence for over 8 years.

The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2018PTC395289. Its GSTIN is 07AAQCA7970E1ZB (Delhi). The company holds 2 GST registrations, all of them active.

The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It was formerly known as Awinsa Life Sceinces Private Limited. It is led by directors Mugdha Chopra and Sanjeev Kumar Miglani.

Its last annual general meeting (AGM) was held on 20 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at E – 13/9 First Floor Vasant Vihar New Delhi, Delhi, India – 110057.

As per the financials filed for FY 2024, the company reported a revenue of ₹21.69 Cr, a growth of 33% compared to the previous year. For the same year it recorded a net profit of ₹6.84 Cr (net margin 31.5%) and EBITDA of ₹9.61 Cr (EBITDA margin 44.3%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 40% over five years.

The company has about 38 employees on its provident fund (EPFO) records.

The company is associated with 1 brand: Awinsa Life Sciences.

For more details, the company can be reached via its website awinsals.com.

Company details

CIN U74999DL2018PTC395289
Registration Number 395289
Incorporation Date 17 April 2018
ROC Delhi
Listing Status Unlisted
Company Status Active

CIN history

Awinsa Life Sciences has one previous CIN (Corporate Identification Number): U74999HR2018PTC073606. The current CIN is U74999DL2018PTC395289, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
U74999DL2018PTC395289Current
U74999HR2018PTC073606Previous

Contact details

Awinsa Life Sciences Private Limited's registered office is in Delhi, Delhi. Its website is awinsals.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    E – 13/9 First Floor Vasant Vihar New Delhi, Delhi, India – 110057
  • Industry
    Business Outsourcing, Medical Transcription

To see the full contact details of Awinsa Life Sciences Private Limited, buy the company report.

Comprehensive company report
Awinsa Life Sciences Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

Awinsa Life Sciences operates one associated brand: Awinsa Life Sciences. Each brand links to its own profile.

BrandDescriptionWebsite
Serves as a CRO specializing in pharmacovigilance services.awinsals.com

Business activity

The main business activity of Awinsa Life Sciences is support service to organizations. In detail, this covers other support services to organizations.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
NSupport service to OrganizationsN7Other support services to organizations

To see the full business activity and turnover split of Awinsa Life Sciences Private Limited, buy the company report.

Financials of Awinsa Life Sciences Private Limited

FY 2025 filings available

Awinsa Life Sciences Private Limited reported revenue of ₹21.69 Cr (up 33% YoY) for FY 2024.

Revenue · FY 2024
₹21.69 Cr ▲ 33%
Net profit · FY 2024
₹6.84 Cr margin 31.5%
EBITDA · FY 2024
₹9.61 Cr margin 44.3%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 33%
3 years · compounded
▲ 33%
5 years · compounded
▲ 40%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 52%
5 years · compounded
▲ 161%

Revenue has grown at a compounded annual rate (CAGR) of 40% over five years, including 33% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹9.61 Cr
Profit Before Tax
Tax Expense
Net Profit (PAT)₹6.84 Cr
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Profitability
EBITDA Margin44.3%
Net Profit Margin31.5%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Awinsa Life Sciences Private Limited, buy the company report.

Board of directors of Awinsa Life Sciences Private Limited

Awinsa Life Sciences has 2 directors on record. No former directors are listed.

Current Directors
NameDesignationAppointment DateTenureStatus
Mugdha ChopraDirector17 Apr 20188 Years 7 MonthsCurrent
Sanjeev Kumar MiglaniDirector17 Apr 20188 Years 7 MonthsCurrent

Auditor

Awinsa Life Sciences Private Limited is audited by J GULATI & CO for the financial year 2022.

Auditor firmFinancial yearFirm registration number
J GULATI & COFY 2022037429N

Shareholding

The shareholding of Awinsa Life Sciences Private Limited is on record for 4 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2022FY 2021FY 2020FY 2019
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Awinsa Life Sciences Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Awinsa Life Sciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Awinsa Life Sciences Private Limited has a workforce of 38 employees on its EPFO records as of May 2026, across 2 active EPFO establishments.

Employee count
38
Active EPFO establishments
2
Employee growth
-13.6%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2738
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22
FY 2020-21

To see the full employee and EPFO history of Awinsa Life Sciences Private Limited, buy the company report.

GST

Awinsa Life Sciences has 2 GST registrations: 2 active.

Total GSTINs
2
Active
2
GSTINStateStatusRegistered on
07AAQCA7970E1ZBDelhiActive21 Jun 2018
06AAQCA7970E1ZDHaryanaActive27 Apr 2018

To see the full GST registrations and return filing status of Awinsa Life Sciences Private Limited, buy the company report.

Recent activity

Awinsa Life Sciences Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Mugdha Chopra was appointed as Director on 17 Apr 2018.

AGM
Awinsa Life Sciences Private Limited last Annual general meeting of members was held on 20 Sep 2025 as per latest MCA records.
Filing
Awinsa Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Appointed
Mugdha Chopra was appointed as Director.
Appointed
Sanjeev Kumar Miglani was appointed as Director.
Incorporation
17 Apr 2018
Awinsa Life Sciences Private Limited was registered on 17 Apr 2018 with Roc Delhi & aged 8 years 7 months as per MCA records.

Frequently asked questions

Awinsa Life Sciences is an active private limited company based in Delhi, India. The company works in medical transcription, within the business outsourcing industry. It was incorporated on 17 April 2018 (8+ years old) and is registered under CIN U74999DL2018PTC395289.

Awinsa Life Sciences has 2 current directors:

The latest financial statements of Awinsa Life Sciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 20 September 2025. Year-wise statements from FY 2019 are in the company report.

The GSTIN of Awinsa Life Sciences is 07AAQCA7970E1ZB, registered in Delhi. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAQCA7970E1ZD (Haryana).

The CIN (Corporate Identification Number) of Awinsa Life Sciences is U74999DL2018PTC395289. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Awinsa Life Sciences was incorporated on 17 April 2018, making it 8+ years old. It is registered with the Registrar of Companies, Delhi.

Mugdha Chopra was appointed as Director on 17 Apr 2018. Sanjeev Kumar Miglani was appointed as Director on 17 Apr 2018.

Awinsa Life Sciences can be reached through the website awinsals.com. Its registered office is in Delhi, India.

The registered office of Awinsa Life Sciences is at E – 139 First Floor Vasant Vihar New Delhi, Delhi, India – 110057.

Awinsa Life Sciences operates in the business outsourcing industry, in the medical transcription segment.